Kezar Life Sciences is a clinical-stage biotechnology company that develops novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, including products like Zetomipzomib for autoimmune hepatitis and KZR-261 for lupus nephritis
Kezar Life Sciences is a clinical-stage biotechnology company that develops novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, including products like Zetomipzomib for autoimmune hepatitis and KZR-261 for lupus nephritis.